Pharmaceuticals Inc (SCPH) reports a 24% revenue increase and strategic advancements, despite facing significant net losses ...
Liquids accounted for 17% of Birchcliff’s total production in Q3 2024 as compared to 19% in Q3 2023. The decrease was largely due to the Corporation continuing to target horizontal natural gas wells ...
Obtained agreement from FDA to initiate a Phase 1 trial evaluating multiple doses of Rhenium (186Re) Obisbemeda for the treatment of patients ...
But a duvet has a shelf life, and there are definite signs you need to replace your duvet. As a sleep-product reviewer who’s ...
Combination Would Create a Global Innovative Services Company with a Unique Set of Differentiated Technologies, a Deep Pipeline, and Best-in-class Industry Team Storage-Area Networking (SAN) DIEGO, ...
The Equipment team talks about preventive maintenance, fluid compatibility, and lifecycle management; Operations talks about ...
His on-court performance reflected his stat sheet stuffing, as Flagg had his prints all over every facet of the basketball ..
Presented full dataset from first-in-human Phase 1a clinical trial demonstrating PMN310 was generally well-tolerated with monthly dosing and that PMN310 demonstrated CSF levels indicative of potential ...
Revenues plunged 22% to £1.08bn with sales down 24% in mainland China as consumers in the world’s second largest economy reined in spending, especially in the second quarter which say a 27% slump.
I'll then provide detailed guidance for our first-quarter results, additional color on our outlook for the full fiscal year, and end with a discussion of both our balance sheet and our land spend ...
In the medical field, being fast, efficient, and correct can be the difference between life and death. This game-changing tool is helping cancer researchers and doctors save lives.
TriSalus Life Sciences, Inc. ( NASDAQ: TLSI) Q3 2024 Earnings Conference Call November 14, 2024 9:00 AM ET Jim Young - Senior Vice President, Investor Relations & Treasurer Mary Szela - President & ...